Palivizumab
(Anti-human RSV-F mAb, human IgG1-Kappa; MEDI-493)
Catalog No.: PC-Ab1100Not For Human Use, Lab Use Only.
Palivizumab (MEDI-493) is a monoclonal antibody to the RSV F protein that inhibits binding of the virus to cellular receptors. This reduces viral activity and cell-to-cell transmission, and blocks the fusion of infected cells. Palivizumab is directed at an epitope in the A antigenic site of the 'F' protein on the surface of RSV. Palivizumab binds to this epitope, which is highly conserved among different RSV isolates..
Palivizumab (MEDI-493) is a monoclonal antibody to the RSV F protein that inhibits binding of the virus to cellular receptors. This reduces viral activity and cell-to-cell transmission, and blocks the fusion of infected cells. Palivizumab is directed at an epitope in the A antigenic site of the 'F' protein on the surface of RSV. Palivizumab binds to this epitope, which is highly conserved among different RSV isolates.
Physicochemical Properties
M.Wt
Formula
Human IgG1-Kappa
Appearance
Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility
PBS, pH 7.0
Contains no stabilizers or preservatives
